irasia.com - Investor Relations Asia Pacific
HOME

The United Laboratories International Holdings Limited
(Incorporated in the Cayman Islands with limited liability)

Announcements & Notices       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2023-November-13
  • GRANT OF AWARD SHARES UNDER THE SHARE AWARD SCHEME (in PDF)
  • 2023-October-26
  • POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 26 OCTOBER 2023 (in PDF)
  • 2023-October-10
  • NOTICE OF ADJOURNED EXTRAORDINARY GENERAL MEETING (in PDF)
  • 2023-October-8
  • TYPHOON ARRANGEMENT FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 9 OCTOBER 2023 (in PDF)
  • 2023-September-26
  • Interim dividend for six months ended 30 June 2023 (in PDF)
  • 2023-September-26
  • FDA APPROVAL OF IND FOR UBT251 INJECTION (in PDF)
  • 2023-September-21
  • Interim dividend for six months ended 30 June 2023 (in PDF)
  • 2023-September-21
  • PAYMENT OF 2023 INTERIM DIVIDEND (in PDF)
  • 2023-September-19
  • INSIDE INFORMATION PLACING OF SHARES BY CONTROLLING SHAREHOLDER (in PDF)
  • 2023-September-14
  • NOTICE OF EXTRAORDINARY GENERAL MEETING (in PDF)
  • 2023-September-13
  • PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION (in PDF)
  • 2023-September-8
  • APPROVAL FOR CLINICAL TRIAL OF THE GROUP'S PRODUCT TUL01101 TABLETS (in PDF)
  • 2023-September-8
  • APPROVAL FOR CLINICAL TRIAL OF UBT251 INJECTION ON INDICATION OF NON-ALCOHOLIC FATTY LIVER DISEASE (in PDF)
  • 2023-September-6
  • UPDATED INFORMATION ON THE GROUP'S PRODUCT IBUPROFEN SUSTAINED-RELEASE CAPSULES (in PDF)
  • 2023-September-6
  • UPDATED INFORMATION OF THE GROUP'S PRODUCTS - MEROPENEM FOR INJECTION (in PDF)
  • 2023-September-3
  • APPROVAL FOR CLINICAL TRIAL OF UBT251 INJECTION ON INDICATION OF OVERWEIGHT OR OBESITY (in PDF)
  • 2023-August-30
  • Interim dividend for six months ended 30 June 2023 (in PDF)
  • 2023-August-29
  • Interim Results Announcement For the six months ended 30 June 2023 (in PDF)
  • 2023-August-29
  • APPROVED FOR CLINICAL TRIAL OF THE GROUP'S PRODUCT UBT251 INJECTION (in PDF)
  • 2023-August-23
  • UPDATED INFORMATION ON THE GROUP'S PRODUCT LIRAGLUTIDE INJECTION (in PDF)
  • 2023-August-17
  • DATE OF BOARD MEETING (in PDF)
  • 2023-August-16
  • POSITIVE PROFIT ALERT (in PDF)
  • 2023-August-4
  • PROPOSED ADOPTION OF THE 2023 SHARE AWARD SCHEME (in PDF)
  • 2023-July-26
  • UPDATED INFORMATION ON THE GROUP'S PRODUCT PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION (in PDF)
  • 2023-July-3
  • Special dividend for the year ended 31 December 2022 (in PDF)
  • 2023-July-3
  • Final dividend for the year ended 31 December 2022 (in PDF)
  • 2023-July-3
  • PAYMENT OF 2022 FINAL DIVIDEND AND SPECIAL DIVIDEND (in PDF)
  • 2023-July-2
  • List of Directors and Their Role and Function (in PDF)
  • 2023-July-2
  • APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEES (in PDF)
  • 2023-June-23
  • POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING (in PDF)
  • 2023-June-16
  • UPDATED INFORMATION ON THE GROUP'S PRODUCT UBT251 INJECTION (in PDF)
  • 2023-April-27
  • NOTICE OF ANNUAL GENERAL MEETING (in PDF)
  • 2023-April-19
  • UPDATED INFORMATION ON THE GROUP'S PRODUCT (in PDF)
  • 2023-April-14
  • UPDATED INFORMATION ON THE GROUP'S PRODUCT (in PDF)
  • 2023-March-31
  • List of Directors and Their Role and Function (in PDF)
  • 2023-March-31
  • RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR (in PDF)
  • 2023-March-27
  • Special dividend for the year ended 31 December 2022 (in PDF)
  • 2023-March-23
  • Special dividend for the year ended 31 December 2022 (in PDF)
  • 2023-March-23
  • Final dividend for the year ended 31 December 2022 (in PDF)
  • 2023-March-22
  • 2022 ANNUAL RESULTS ANNOUNCEMENT (in PDF)
  • 2023-March-14
  • POSITIVE PROFIT ALERT (in PDF)
  • 2023-March-8
  • DATE OF BOARD MEETING (in PDF)
  • 2023-March-3
  • UPDATED INFORMATION ON THE GROUP'S PRODUCT TUL12101 EYE DROPS (in PDF)
  • 2024
  • 2024 Announcements & Notices
  • 2022
  • 2022 Announcements & Notices
  • 2021
  • 2021 Announcements & Notices
  • 2020
  • 2020 Announcements & Notices
  • 2019
  • 2019 Announcements & Notices
  • 2018
  • 2018 Announcements & Notices
  • 2017
  • 2017 Announcements & Notices
  • 2016
  • 2016 Announcements & Notices
  • 2015
  • 2015 Announcements & Notices
  • 2014
  • 2014 Announcements & Notices
  • 2013
  • 2013 Announcements & Notices
  • 2012
  • 2012 Announcements & Notices
  • 2011
  • 2011 Announcements & Notices
  • 2010
  • 2010 Announcements & Notices
  • 2009
  • 2009 Announcements & Notices
  • 2008
  • 2008 Announcements & Notices
  • 2007
  • 2007 Announcements & Notices


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2023 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.

    Close